28
Oct
2025

i+Med S. Coop.

Exhibitor at CPHI Frankfurt 2025 stand 3.1B42, Finished Dosage Formulations
About Us

i+Med is a leading pharmaceutical company dedicated to the development, manufacture and commercialisation of injectables, eye drops and topical products for the therapeutic areas of traumatology, aesthetics, ophthalmology, dermatology and women's health. 

We are world experts in hydrogels and and smart nanohydrogels technologies. Under our controlled release technologies patents we develop innovative formulas and products. A more than 150 people unique Cooperative of scientists.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • ES
  • 2018
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Contract Service
Distributor/Import Export
Manufacturer/Innovator
OTC
Pharmaceutical company
Veterinary Company
Primary activities
Contract Manufacturer
Medical Devices
OTC
Out-licensing specialist
Pharmaceutical Company (innovator finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 3.1B42, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2025

  • BtHLINE and BtHCROSS - Dermal fillers for aestheic medicine (Linear HA 1,4%, Crosslinked HA 1,5%, 1,75%, 2%)

    Product BtHLINE and BtHCROSS - Dermal fillers for aestheic medicine (Linear HA 1,4%, Crosslinked HA 1,5%, 1,75%, 2%)

    BtHLINE 1,4% is a biocompatible linear hyaluronic acid hydrogel intended as a dermatologicaltreatment for aesthetic purposes. Administered by intradermal injection.

    Composition
    Non-animal HA Low level of endotoxins
    Properties
    BtHLINE 1,4% + Restores aged skin structures. ...
  • Daydrop - controlled release multidose eye drops with ectoine for dry eye

    Product Daydrop - controlled release multidose eye drops with ectoine for dry eye

    DayDrop is an eye drop indicated to relieve dryness and eye irritation caused by environmental factors (wind, dust, smoke, air conditioning, dry heat), prolonged use of screens or contact lenses and / or certain ocular pathologies that occur with these symptoms.
    Hydrates, lubricates and protects for...
  • DayDrop - eye drops with 12h sustained-release system of ectoine

    Product DayDrop - eye drops with 12h sustained-release system of ectoine

    DAYDROP. INNOVATIVE FORMULA WITH HIALURONIC ACID AND 12h SUSTAINED RELEASE OF ECTOINE Eye drops indicated to relieve dryness and eye irritation caused by environmental factors (wind, dust, smoke, air conditioning, dry heat), prolonged use of screens or contact lenses and / or certain ocular pathologies th...
  • ADAPTEK® TECHNOLOGY

    Product ADAPTEK® TECHNOLOGY

    ADAPTEK® TECHNOLOGY is the general name for our 4 international patents and expertise in nanotechnology and controlled release systems.This is a transversal technology that allows to develop customized biopolymeric nanohydrogels, allowing the load with different API (drugs, vitamins, growth factors, etc.)....
  • OpHLINE - Ophthalmic Viscosurgical Devices (HA 1,4%/2%/3%)

    Product OpHLINE - Ophthalmic Viscosurgical Devices (HA 1,4%/2%/3%)

    OpHLINE is an ophthalmic viscosurgical devise (OVD) indicated as a coadjuvant during surgical procedures, involving the anterior chamber of the eye, especially in cataract surgery, including the extraction of the lens and the insertion of intraocular lenses.
    OpHLINE is available in 3 models ...
  • TrHCROSS - Joint injections (cross-linked HA 2%)

    Product TrHCROSS - Joint injections (cross-linked HA 2%)

    TrHCROSS 2% is a biocompatible hydrogel of cross-linked sodium hyaluronate obtained by biofermentation. This is a single injection, designed to relieve joint pain in osteoarthritis by replacing natural joint fluid and replenishing lubricating and shock-absorbing functions.

    Properties
    ...
  • BtHCROSS - Dermal filler (cross-linked HA 1,5%/1,75%/2%)

    Product BtHCROSS - Dermal filler (cross-linked HA 1,5%/1,75%/2%)

    BtHCROSS is a biocompatible cross-linked hyaluronic acid hydrogel intended as a dermatological treatment for aesthetic purposes. It is administered by intradermal injection and designed to restore and correct facial volumes and fill wrinkles and folds.
    Depending on the depth of the wrinkles an...
  • DayDrop - eye drops with the sustained-release system of ectoine

    Product DayDrop - eye drops with the sustained-release system of ectoine

    DayDrop is an ophthalmic solution with sustained release of ectoine, indicated to alleviate the ocular dryness and irritation produced by environmental factors (wind, dust, air conditioning, dry heat), prolonged use of screens or contact lenses and some pathologies that present the above mentioned symp...
  • Profilm COLD SORES - protective film for cold sores(herpes)

    Product Profilm COLD SORES - protective film for cold sores(herpes)

    Profilm COLD SORES is a liquid dressing for topical use, indicated to relieve the initial symptoms of cold sores. Its technology firms a protective and discreet physical barrier that adapts to the shape of the skin, reducing the risk of infection and the spread of the virus. Due to its composi...
  • Profilm MOUTH ULCERS - protective film for mouth ulcers and aphthae

    Product Profilm MOUTH ULCERS - protective film for mouth ulcers and aphthae

    Profilm MOUTH ULCERS is a hydrogel, supplemented with natural extracts of propolis and tea tree, and enriched with stabilized vitamin C. After its application, and thanks to its technology, a protective physical barrier is formed which adapts to the shape of the mucosa, preventing contact with...
  • BuddyDrops - eye drops with ectoine and HA for veterinary use

    Product BuddyDrops - eye drops with ectoine and HA for veterinary use

    BuddyDrops is a sterile moisturizing and lubricating long-lasting ophthalmic solution intended for veterinary use. BuddyDrops increases the contact time of the drop on the ocular surface reducing the need for repeated applications of the product and thus improving therapeutic compliance.

    ...